Open access peer-reviewed chapter

Adjuvant Interferon Gamma in the Management of Multidrug - Resistant Tuberculosis

By Idrian García-García, María T Milanés-Virelles, Pedro A López-Saura, Roberto Suárez-Méndez, Magalys Valdés-Quintana, Norma Fernández-Olivera, Carmen M Valenzuela-Silva, Lidia González- Méndez, Yamilet Santos-Herrera, Gladys Abreu-Suárez and Isis Cayón-Escobar

Submitted: March 13th 2011Reviewed: September 7th 2011Published: February 24th 2012

DOI: 10.5772/29906

Downloaded: 2204

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Idrian García-García, María T Milanés-Virelles, Pedro A López-Saura, Roberto Suárez-Méndez, Magalys Valdés-Quintana, Norma Fernández-Olivera, Carmen M Valenzuela-Silva, Lidia González- Méndez, Yamilet Santos-Herrera, Gladys Abreu-Suárez and Isis Cayón-Escobar (February 24th 2012). Adjuvant Interferon Gamma in the Management of Multidrug - Resistant Tuberculosis, Understanding Tuberculosis, Pere-Joan Cardona, IntechOpen, DOI: 10.5772/29906. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/understanding-tuberculosis-analyzing-the-origin-of-mycobacterium-tuberculosis-pathogenicity/adjuvant-interferon-gamma-in-the-management-3-of-multidrug-resistant-tuberculosis" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

2204total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Biochemical and Immunological Characterization of the Mycobacterium tuberculosis 28 kD Protein

By Elinos-Báez Carmen Martha and Ramírez González

Related Book

First chapter

Multi-Drug/Extensively Drug Resistant Tuberculosis (Mdr/Xdr-Tb): Renewed Global Battle Against Tuberculosis?

By Claude Kirimuhuzya

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us